We scored 50 of the most-watched biotech websites on 100 points: speed, message clarity, proof, path to contact, mobile, accessibility, AI-search readiness and freshness. The median site scored 72.4. The difference between good and great was rarely the technology. It was whether a visitor could tell what the company does in five seconds.
The top 10 biotech websites of 2026
The two highest scores went to a cell and gene therapy manufacturer and a cell therapy startup, ahead of every large commercial biotech. Both did the one thing most sites skip: they said plainly what they do.
| # | Company | Total /100 | Clarity /20 | Speed /20 | Proof /15 | AI search /10 |
|---|---|---|---|---|---|---|
| 1 | ElevateBioPlatform startups | 87.4 | 20 | 12 | 12 | 10 |
| 2 | Arsenal BioGene and cell therapy | 86.4 | 20 | 17.8 | 9 | 8 |
| 3 | RegeneronLarge and commercial | 85.9 | 12 | 16 | 15 | 10 |
| 4 | GileadLarge and commercial | 84.3 | 16 | 12 | 15 | 8 |
| 5 | argenxLarge and commercial | 83.4 | 16 | 16 | 12 | 5 |
| 6 | AbsciAI-first discovery | 83.1 | 16 | 16.5 | 15 | 8 |
| 7 | VertexLarge and commercial | 81.9 | 12 | 18 | 12 | 8 |
| 8 | MedpaceCROs, CDMOs and tools | 81.9 | 12 | 16.5 | 15 | 8 |
| 9 | Tessera TherapeuticsGene and cell therapy | 81.0 | 20 | 20 | 3 | 8 |
| 10 | Iambic TherapeuticsAI-first discovery | 80.7 | 16 | 15.5 | 12 | 3 |
Biotech sites are built well and explained poorly
Average share of available points in each category. Accessibility, freshness and mobile basics are largely solved. Message clarity, proof and AI-search readiness are where most sites lose ground.
Only 5 of 49 homepages were clear in five seconds
We showed each homepage’s first screen for five seconds, then wrote down what the company does and rated how clear it was. Most sites landed in the middle: a reviewer could guess the field, but not the product, the audience or why it’s different.
Clarity tracked with everything else. Sites with a perfect clarity score averaged 82 overall. Sites rated 3 averaged 71. Teams that can say what they do tend to build the rest of the site around it.
What the clearest homepages do
Arsenal Bio leads with next-generation in vivo cell therapy. Tessera owns a category name, gene writing. Visitors know the field before they read a second line.
Cradle’s headline is “Better proteins. Fewer experiments. Faster to product.” Enveda and Twist Bioscience both lead with how much faster they are. A number turns a claim into a reason.
Several of the largest companies use the first screen for a news story or campaign. It’s timely, but a first-time visitor leaves without knowing what the company does.
Autoplay video with no text, and taglines that could belong to any biotech, scored lowest. If the headline still works with the logo covered, it’s too generic.
Most biotech sites aren’t ready for AI search
ChatGPT, Perplexity and Google’s AI answers describe companies using what they can read on the site. Most sites make that harder than it needs to be.
The science is there. The evidence is hard to find.
We checked whether pipeline, publications, partners and data or results are reachable within one click of the homepage.
Nearly every site has a science page. Only 24 of 49 link to their publications from the homepage, and 27 show data or results. For a partner doing diligence, peer-reviewed work is the strongest proof a biotech has. It shouldn’t take a search to find it.
Fast enough for most, heavy for many
Speed is measured with Google’s real-visitor data (Chrome UX Report) where Google has enough traffic, which covered 40 of the sites.
The usual culprits are hero videos, uncompressed images and animation libraries. Prime Medicine, Tessera and Relay earned full speed marks, which shows a science-heavy site doesn’t have to be a slow one.
Every site recruits. Fewer invite partners.
How each group scored
Average total score out of 100, with the top site in each group. We grouped the 50 sites so each company is compared with its peers.
Who to study
ElevateBio, Arsenal Bio, Tessera Therapeutics, Cradle, Enveda
Regeneron, Gilead, Absci, Medpace, Schrödinger
ElevateBio, Regeneron, Lyell Immunopharma, Enveda
Tessera Therapeutics, Prime Medicine, Relay Therapeutics, Ginkgo Bioworks, Beam Therapeutics
Tessera Therapeutics, Moderna
Regeneron, Arsenal Bio, Absci, Medpace, ElevateBio
Six fixes that would move most biotech sites up the list
Say what you make, for whom, and what’s different, ideally with a number. Test it on someone outside the company for five seconds.
Put peer-reviewed work and data one click from the homepage.
Give business development its own entry point and contact.
Two small files that help search engines and AI tools describe you correctly.
Compress the hero video and images. Aim for under 3 MB.
One H1, a meta description, and nothing covering the first screen on a phone.
Download the PDF
All the findings in a 10-page report: the leaderboard, category and group scores, the clarity results, who to study, and our full method. Free, sent straight to your inbox.
"*" indicates required fields
How would your site score?
We’ll run your homepage through the same 100-point benchmark and send you a one-page scorecard with the three fixes we’d make first.
Get your free scorecardPrepared by Wizardly · wizardly.co